2d55: Difference between revisions

No edit summary
No edit summary
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:2d55.jpg|left|200px]]


{{Structure
==Structural, physical and biological characteristics of RNA.DNA binding agent N8-actinomycin D==
|PDB= 2d55 |SIZE=350|CAPTION= <scene name='initialview01'>2d55</scene>, resolution 3.000&Aring;
<StructureSection load='2d55' size='340' side='right'caption='[[2d55]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
|SITE=  
== Structural highlights ==
|LIGAND= <scene name='pdbligand=PXZ:2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO-PHENOXAZIN-3-ONE'>PXZ</scene>, <scene name='pdbligand=SAR:SARCOSINE'>SAR</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=DTH:D-THREONINE'>DTH</scene>, <scene name='pdbligand=DVA:D-VALINE'>DVA</scene> and <scene name='pdbligand=DPR:D-PROLINE'>DPR</scene>
<table><tr><td colspan='2'>[[2d55]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptomyces_antibioticus Streptomyces antibioticus]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=1d55 1d55]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D55 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2D55 FirstGlance]. <br>
|ACTIVITY=  
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
|GENE=  
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DVA:D-VALINE'>DVA</scene>, <scene name='pdbligand=MVA:N-METHYLVALINE'>MVA</scene>, <scene name='pdbligand=PXZ:2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO-PHENOXAZIN-3-ONE'>PXZ</scene>, <scene name='pdbligand=SAR:SARCOSINE'>SAR</scene></td></tr>
}}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2d55 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2d55 OCA], [https://pdbe.org/2d55 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2d55 RCSB], [https://www.ebi.ac.uk/pdbsum/2d55 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2d55 ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The crystal structures of the 2:1 complex of the self-complementary DNA octamer d(GAAGCTTC) with actinomycin D has been determined at 3.0 A resolution. This is the first example of a crystal structure of a DNA-drug complex in which the drug intercalates into the middle of a relatively long DNA segment. The results finally confirmed the DNA-actinomycin intercalation model proposed by Sobell &amp; co-workers in 1971. The DNA molecule adopts a severely distorted and slightly kinked B-DNA-like structure with an actinomycin D molecule intercalated in the middle sequence, GC. The two cyclic depsipeptides, which differ from each other in overall conformation, lie in the minor groove. The complex is further stabilized by forming base-peptide and chromophore-backbone hydrogen bonds. The DNA helix appears to be unwound by rotating one of the base-pairs at the intercalation site. This single base-pair unwinding motion generates a unique asymmetrically wound helix at the binding site of the drug, i.e. the helix is loosened at one end of the intercalation site and tightened at the other end. The large unwinding of the DNA by the drug intercalation is absorbed mostly in a few residues adjacent to the intercalation site. The asymmetrical twist of the DNA helix, the overall conformation of the two cyclic depsipeptides and their interaction mode with DNA are correlated to each other and rationally explained.


'''STRUCTURAL, PHYSICAL AND BIOLOGICAL CHARACTERISTICS OF RNA.DNA BINDING AGENT N8-ACTINOMYCIN D'''
Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D.,Kamitori S, Takusagawa F J Mol Biol. 1992 May 20;225(2):445-56. PMID:1593629<ref>PMID:1593629</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
==Overview==
</div>
The crystal structure of the self-complementary DNA octamer d(GAAGCTTC)2 complexed with N8-actinomycin D (N8AMD) has been determined at 3.0 A resolution (space group: P3(1)21; unit cell: a = 62.30, b = 62.30, c = 42.97 A; R = 0.173 for 1845 reflections). The DNA structure was severely distorted by the N8AMD bound intercalatively into the middle dinucleotide, 5'-GC-3'. The two cyclic depsipeptides, which differ from each other in overall conformation, lie in the minor groove. The complex is further stabilized by forming base--peptide and chromophore--backbone hydrogen bonds. The complexes are stacked together to form a pseudocontinuous helix running through the crystals. The structure of d(GAAGCTTC)2-actinomycin D (AMD) crystallized in the space group C2 [Kamitori S., &amp; Takusagawa, F. (1992) J. Mol. Biol. 225, 445-456] was re-refined in order to compare it directly to the N8AMD complex structure. The asymmetrical binding mode of AMD has been confirmed on the basis of the two complex structures. The crystal structures of the N8AMD and AMD complexes bound to the same d(GAAGCTTC)2 differed by a root-mean-square deviation on all atom positions of 1.77 A, but most of the structural differences can be attributed to molecular packing in two different crystal forms, and not to structural differences induced by the interaction with the intercalating agents. However, the DNA binding and biological characteristics of N8AMD and AMD are quite different from each other. The DNA association constant of N8AMD is 33-fold less than that of AMD in an aqueous solution. N8AMD required a concentration &gt; 10.0 microM to inhibit RNA synthesis activity in HeLa cells by 50%, whereas AMD reached to the same inhibitory level at only 35 nM. The structure of the DNA-N8AMD complex suggested that substitution of the N-methyl-L-valine residue in the cyclic depsipeptide with a N-methyl-D-valine residue might increase the hydrophobic interaction with the minor groove of the DNA. Thus the DNA association constant and RNA synthesis inhibitory activities of 5,5'-N-methyl-D-valine AMD (D-MeVal-AMD) have also been determined. The DNA association constant of D-MeVal-AMD is more than 2-fold greater than that of AMD, and the RNA synthesis inhibitory activity is about 20-fold greater.
<div class="pdbe-citations 2d55" style="background-color:#fffaf0;"></div>
 
== References ==
==About this Structure==
<references/>
2D55 is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. This structure supersedes the now removed PDB entry 1D55. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D55 OCA].
__TOC__
 
</StructureSection>
==Reference==
[[Category: Large Structures]]
Structural, physical, and biological characteristics of RNA.DNA binding agent N8-actinomycin D., Shinomiya M, Chu W, Carlson RG, Weaver RF, Takusagawa F, Biochemistry. 1995 Jul 4;34(26):8481-91. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7541244 7541244]
[[Category: Streptomyces antibioticus]]
[[Category: Protein complex]]
[[Category: Carlson RG]]
[[Category: Carlson, R G.]]
[[Category: Chu W]]
[[Category: Chu, W.]]
[[Category: Shinomiya M]]
[[Category: Shinomiya, M.]]
[[Category: Takusagawa F]]
[[Category: Takusagawa, F.]]
[[Category: Weaver RF]]
[[Category: Weaver, R F.]]
[[Category: DPR]]
[[Category: DTH]]
[[Category: DVA]]
[[Category: MVA]]
[[Category: PXZ]]
[[Category: SAR]]
[[Category: complexed with drug]]
[[Category: double helix]]
[[Category: right handed dna]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:23:27 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA